APA (7th ed.) Citation

MR, C., VM, I., N, L., & CB, K. (2020). Developing a new class of engineered live bacterial therapeutics to treat human diseases. Nature communications, 11(1), 1738. https://doi.org/10.1038/s41467-020-15508-1

Chicago Style (17th ed.) Citation

MR, Charbonneau, Isabella VM, Li N, and Kurtz CB. "Developing a New Class of Engineered Live Bacterial Therapeutics to Treat Human Diseases." Nature Communications 11, no. 1 (2020): 1738. https://doi.org/10.1038/s41467-020-15508-1.

MLA (9th ed.) Citation

MR, Charbonneau, et al. "Developing a New Class of Engineered Live Bacterial Therapeutics to Treat Human Diseases." Nature Communications, vol. 11, no. 1, 2020, p. 1738, https://doi.org/10.1038/s41467-020-15508-1.